Introduction
Systemic Arterial Hypertension (SAH) is currently considered one of the main chronic diseases in the world and one of the greatest public health challenges (1) . In the last few years, SAH has been increasingly predominant and a major risk factor for cardiovascular diseases (1) (2) .
In a systematic review that included 44 studies in 35 countries, held from 2003 to 2008, a global predominance of SAH was shown in 37.8% of men and in 32.1% of women (3) . In Brazil, in 2010, data collected from DATASUS pointed out that 23.3% of the population over the age of 18 reported previous medical diagnosis of hypertension (weighted percentage to adjust the socio demographic distribution of VIGITEL sample to the distribution of the adult population of Census 2000) (4) . A study involving the elderly population showed that 34.9% of all reported diseases referred to self-reported hypertension (5) .
The main purpose of treating SAH is to reduce the morbidity and mortality associated with high levels of blood pressure. The benefits of this treatment in relation to this reduction are effectively demonstrated. It is estimated that 40% of cerebrovascular accidents and about 25% of strokes in hypertensive patients can be prevented with appropriate anti-hypertensive therapy (3) .
Despite the clinical benefits provided by the treatment, anti-hypertensive medications can have adverse effects, as well as the SAH itself, considering that the stigma of the diagnosis and the impact of its clinical expression may affect the pleasure of living (6) . Therefore, one important aspect in the assessment and approach of hypertensive patients is the health related quality of life (HRQoL).
A baseline study carried out with hypertensive patients showed a reduced HRQoL among hypertensive patients when compared to the group without hypertension. When associating SAH with other comorbidities, an additional reduction of the HRQoL could be observed (7) . These results indicate two important findings. The first relates to the importance of assessing the HRQoL of patients with cardiovascular diseases. The second is related to the relevance of providing a measure that is applicable to patients with cardiovascular diseases, with the purpose of measuring the same HRQoL construct and permitting intergroup comparison.
In the international literature, there are few specific instruments to assess the HRQoL of hypertensive patients, with emphasis on the Hypertension Health Status Inventory -HYPER 31 (8) , the Arterial Hypertension Quality of Life Questionnaire -Calidad de Vida en la Hipertensión Arterial -CHAL (9) and its reduced version of the Mini-Cuestionario de Calidad de Vida en la Hipertension Arterial -Minichal (10) , which includes subjective aspects and somatic expressions, without restricting the evaluation of the effects of drug therapy on patients' HRQoL.
Several generic and specific instruments have been validated for the assessment of HRQoL in patients with heart diseases (11) (12) , but studies aimed at measuring the perceived disease impact on the daily life of these people in a deeper way are rare.
In order to assess people's perception regarding the impact of the disease on daily life, the IDCV -Instrument to Measure the Impact of Coronary Disease on Patient's Daily Life -was developed, based on the Brazilian population, and is aimed at measuring the impact of coronary disease on patients (13) . This instrument was
shown to be valid and reliable when used in coronary disease patients being treated at outpatient clinics (14) .
After validation studies of the IDCV (14) , it was found that, due to the range of its items, it would also be possible to use the instrument in patients suffering from other cardiovascular diseases (15) . Thus, the study which applied the IDCV in patients with coronary artery disease was conducted. Interestingly, the IDCV showed good psychometric performance, with evidences of internal consistency and construct validity (16) , similar to the previous IDCV validation study involving coronary disease patients (14) .
These findings suggested a new perspective on the use of the IDCV and aroused the interest in also investigating its measuring properties in relation to other groups of cardiovascular diseases, which share the symptoms and the chronic nature, such as the SAH.
This study investigated the acceptability, feasibility, 
Method
Place of study and, the higher the score, the worse the assessment of patients about the statement (14) . The higher the score, the higher the negative impact perceived by people and, on the contrary, the lower the score, the lower the perceived negative impact of the disease (14) .
Data collection
The total score of the IDCV is estimated based on the sum of all products obtained, and varies from 14
to 350.
Data analysis
The data collected were entered into an electronic -Feasibility, acceptability and ceiling and floor effect:
The feasibility of the IDCV was assessed through the time spent to complete the instrument. The practical aspects of the measure/acceptability were assessed by the percentage of unanswered items and the proportion of patients who had not answered all items (17) . For the floor effect analysis, the percentage of patients who scored floor was calculated, that is, those who showed the worst 10% results in the IDCV, which are the 10% highest scores (which indicate higher negative impact of the disease) (17) , for both the total IDCV (≥316. 4) and for its domains (Physical Impact of the Disease - The percentage of patients who scored ceiling (17) was also estimated, that is, those who showed the 10% best possible results in the scale (thus, the lowest scores, which mean a lower negative impact: Up to 25%, it was considered moderate ceiling and floor effect and, higher than 25%, it was considered substantial (18) .
-Reliability: The reliability was assessed by estimating the measurement error, according to the temporal stability of the measure criterion, which is the consistency among repeated measures (test/retest) by means of the intraclass correlation coefficient and by internal consistency (Cronbach alpha coefficient) (16) . A Cronbach alpha coefficient >0.70 (19) was considered as evidence of internal consistency, and a coefficient >0.70 (20) (21) of temporal stability.
Ethical aspects
This study received approval from the local Research
Ethics Committee (Registration number 1116/2010), and all patients listed signed an Informed Consent Term.
Results

Socio demographic and clinical data
The socio demographic and clinical characteristics of the 137 participants are presented in 
Feasibility, Acceptability and Ceiling and Floor Effect and Descriptive Measures of the IDCV
The average time to complete the IDCV at Tt was 
Reliability of the IDCV
In order to assess reliability, the temporal stability and the internal consistency criteria presented in tables 3 and 4, respectively, were considered.
To assess temporal stability, the IDCV was reapplied to 88 patients at Trt, with an interval of 7 to 21 days. Pavan RBB, Padilha KM, Rodrigues SLL, Rodrigues RCM, Gallani MCJB. 
Discussion
This study was aimed at assessing the practical aspects of the measure in relation to the use of the IDCV in hypertensive patients, verifying its feasibility, acceptability, ceiling and floor effects and reliability. The findings showed that the use of the instrument in this group of patients is feasible.
The feasibility and acceptability are important aspects to be evaluated in relation to an instrument that is developed, adapted or tested in a population that is different from that it was originally developed for.
The analysis of these properties permits verifying the instrument's feasibility for the new target population.
The study findings evidence these properties, since there is a low onus to the respondent as a result of the eight-minute average time for its use, besides the fact that no unanswered items were registered. These data show the IDCV performance in patients with coronary artery disease (15) . However, it should be emphasized that, in both studies, the instrument was applied in the form of an interview, which can reduce the chances of unanswered items.
The analysis of the ceiling and floor effects, based on the analysis of the distribution of scores (total and domains), showed that the IDCV is an instrument potentially capable of detecting improvement or worsening in the perception of HRQoL over time (20) .
The ceiling effect is confirmed when there is asymmetric distribution of scores and a significant percentage of the population in the study scores at the highest levels of the measure. This means that, if the subject who scored at the extreme range of the scale presents an improvement in the perceived HRQoL, the instrument will not be able to detect it.
The IDCV as a whole showed no ceiling effect, nor did its domains, except for Adjustment to the Disease, which showed a moderate ceiling effect, similar to the study undertaken with coronary disease patients (15) . This means that the IDCV, when applied to hypertensive patients, is potentially capable of detecting improvements in the perception of HRQoL over time.
The floor effect, in turn, reflects the percentage of subjects who score at the lowest levels of the measure.
This type of asymmetric distribution makes it hard to detect the worsening in the assessed subjects' perceived HRQoL (17) . A slight floor effect (12.4%) was observed among hypertensive patients, only in relation to the domain Physical Impact of the Disease -Symptoms, and
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this effect was even smaller than that verified among patients with coronary artery diseases (49.0%) (15) .
The investigation of the ceiling and floor effects is important because, if observed in many domains, these effects can lead to the limitation of another psychometric property: responsiveness. This property, also important, is related to the instrument's ability to detect and estimate the magnitude of change in the health status over time (20) .
Whereas one of the methods for assessing responsiveness consists of an approach based on the longitudinal distribution of the sample, any reduction in the variability of the scores, that is, ceiling and floor effects can minimize the sensibility to detect differences and the responsiveness to change (21) (22) .
Another property involved in the feasibility of the responsiveness assessment of an instrument is the demonstration of its temporal stability. Within a certain range, which is variable according to the studied concept, it is important that the subjects' answers to the instrument do not vary substantially, since there is no greater modification factor that may affect their perception of the studied concept. This property is named temporal stability and was assessed in the range 7 to 21 days in this study. High levels of consistency between the test/retest were observed, in relation to the total score as well as all domains of the IDCV. (14) (15) , presented low homogeneity.
This is a domain constituted by only two items, which reduces the variability of its score. In addition, the development characteristic of these two items can cause double interpretation and, as a result, inconsistency in the scores given by the patient to answer the question. 
Conclusion
The use of the IDCV in hypertensive patients showed to be feasible, acceptable and potentially sensitive to detect worsening or improvement in the perceived disease impact evidenced by the absence of ceiling and floor effect in the total score of the IDCV and in most of its domains. The findings indicate that the instrument is reliable in relation to temporal stability and internal consistency. The validity properties of the IDCV in hypertensive patients will be disclosed in a subsequent article.
